Pharmacological approaches to the treatment of tinnitus

Drug Discovery Today

Volumn 15, Issue 7-8, 2010, Pages 300-305

  Elgoyhen, Ana B ^a,b   Langguth, Berthold ^c  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALPRAZOLAM; AMITRIPTYLINE; ATORVASTATIN; BENZODIAZEPINE; CARBAMAZEPINE; CLONAZEPAM; CYCLANDELATE; DIAZEPAM; DULOXETINE; EBSELEN; FUROSEMIDE; GABAPENTIN; GINKGO BILOBA EXTRACT; LAMOTRIGINE; LIDOCAINE; MEMANTINE; MISOPROSTOL; NERAMEXANE; NIMODIPINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE; VESTIPITANT;

CLINICAL TRIAL; COGNITIVE THERAPY; DISEASE SEVERITY; DRUG INDUSTRY; EAR DISEASE; FEEDBACK SYSTEM; HEAD AND NECK INJURY; HUMAN; LOUDNESS RECRUITMENT; NOISE; PATIENT COUNSELING; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK FACTOR; STRESS; TINNITUS; VESTIBULOCOCHLEAR NERVE DISEASE; VISUAL ANALOG SCALE;

ANIMALS; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; TINNITUS;

EID: 77951024683     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.11.003     Document Type: Review

References (69)

1. Eggermont J.J., Roberts L.E. The neuroscience of tinnitus. Trends Neurosci. 2004, 27:676-682.
2. Moller A.R. Tinnitus: presence and future. Prog. Brain Res. 2007, 166:3-16.
3. Kemp D.T. Otoacoustic emissions, travelling waves and cochlear mechanisms. Hear. Res. 1986, 22:95-104.
4. Ahmad N., Seidman M. Tinnitus in the older adult: epidemiology, pathophysiology and treatment options. Drugs Aging 2004, 21:297-305.
5. Vio M.M., Holme R.H. Hearing loss and tinnitus: 250 million people and a US10 billion potential market. Drug Discov. Today 2005, 10:1263-1265.
6. Axelsson A., Prasher D. Tinnitus induced by occupational and leisure noise. Noise Health 2000, 2:47-54.
7. Lynch E.D., Kil J. Compounds for the prevention and treatment of noise-induced hearing loss. Drug Discov. Today 2005, 10:1291-1298.
8. Lim D.J. Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review. Am. J. Otolaryngol. 1986, 7:73-99.
9. Biassoni E.C., et al. Recreational noise exposure and its effects on the hearing of adolescents. Part II. Development of hearing disorders. Int. J. Audiol. 2005, 44:74-85.
10. McShane D.P., et al. Tinnitus prevalence in industrial hearing loss compensation claimants. Clin. Otolaryngol. Allied Sci. 1988, 13:323-330.
11. Langguth B., et al. Repetitive transcranial magnetic stimulation and chronic tinnitus. Acta Otolaryngol. Suppl. 2006, 556:102-105.
12. Van de Heyning P., et al. Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation. Ann. Otol. Rhinol. Laryngol. 2008, 117:645-652.
13. Goodey R. Tinnitus treatment: state of the art. Prog. Brain Res. 2007, 166:237-246.
14. Dohrmann K., et al. Neurofeedback for treating tinnitus. Prog. Brain Res. 2007, 166:473-485.
15. Jastreboff P.J., Jastreboff M.M. Tinnitus retraining therapy: a different view on tinnitus. ORL J. Otorhinolaryngol. Relat. Spec. 2006, 68:23-29.
16. Darlington C.L., Smith P.F. Drug treatments for tinnitus. Prog. Brain Res. 2007, 166:249-262.
17. Dobie R.A. A review of randomized clinical trials in tinnitus. Laryngoscope 1999, 109:1202-1211.
18. Patterson M.B., Balough B.J. Review of pharmacological therapy for tinnitus. Int. Tinnitus J. 2006, 12:149-159.
19. House J.W., Brackmann D.E. Tinnitus: surgical treatment. Ciba Found. Symp. 1981, 85:204-216.
20. Kaltenbach J.A., Godfrey D.A. Dorsal cochlear nucleus hyperactivity and tinnitus: are they related?. Am. J. Audiol. 2008, 17:S148-S161.
21. Bauer C.A., et al. Tinnitus and inferior colliculus activity in chinchillas related to three distinct patterns of cochlear trauma. J. Neurosci. Res. 2008, 86:2564-2578.
22. Melcher J.R., et al. Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J. Neurophysiol. 2000, 83:1058-1072.
23. Schlee W., et al. Abnormal resting-state cortical coupling in chronic tinnitus. BMC Neurosci. 2009, 10:11.
24. Smits M., et al. Lateralization of functional magnetic resonance imaging (fMRI) activation in the auditory pathway of patients with lateralized tinnitus. Neuroradiology 2007, 49:669-679.
25. Duckert L.G., Rees T.S. Treatment of tinnitus with intravenous lidocaine: a double-blind randomized trial. Otolaryngol. Head Neck Surg. 1983, 91:550-555.
26. Langguth B., et al. Emerging pharmacotherapy of tinnitus. Expert Opin. Emerg. Drugs 2009, 14:687-702.
27. Belli S., et al. Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus. Eur. Arch. Otorhinolaryngol. 2008, 265:279-285.
28. Robinson S.K., et al. Antidepressant therapy in tinnitus. Hear. Res. 2007, 226:221-231.
29. Zoger S., et al. Relationship between tinnitus severity and psychiatric disorders. Psychosomatics 2006, 47:282-288.
30. Mico J.A., et al. Antidepressants and pain. Trends Pharmacol. Sci. 2006, 27:348-354.
31. Moller A.R. Tinnitus and pain. Prog. Brain Res. 2007, 166:47-53.
32. Sullivan M., et al. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch. Intern. Med. 1993, 153:2251-2259.
33. Katon W., et al. Depressive symptoms and measures of disability: a prospective study. J. Affect. Disord. 1993, 27:245-254.
34. Zoger S., et al. The effects of sertraline on severe tinnitus suffering - a randomized, double-blind, placebo-controlled study. J. Clin. Psychopharmacol. 2006, 26:32-39.
35. Robinson S. Antidepressants for treatment of tinnitus. Prog. Brain Res. 2007, 166:263-271.
36. Johnson R.M., et al. Use of alprazolam for relief of tinnitus. A double-blind study. Arch. Otolaryngol. Head Neck Surg. 1993, 119:842-845.
37. Kay N.J. Oral chemotherapy in tinnitus. Br. J. Audiol. 1981, 15:123-124.
38. Gananca M.M., et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int. Tinnitus J. 2002, 8:50-53.
39. Bahmad F.M., et al. Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. Int. Tinnitus J. 2006, 12:140-144.
40. Ettinger A.B., Argoff C.E. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain. Neurotherapeutics 2007, 4:75-83.
41. Levine R.A. Typewriter tinnitus: a carbamazepine-responsive syndrome related to auditory nerve vascular compression. ORL J. Otorhinolaryngol. Relat. Spec. 2006, 68:43-46.
42. Mardini M.K. Ear-clicking " tinnitus" responding to carbamazepine. N. Engl. J. Med. 1987, 317:1542.
43. Bauer C.A., Brozoski T.J. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2006, 116:675-681.
44. Witsell D.L., et al. Treatment of tinnitus with gabapentin: a pilot study. Otol. Neurotol. 2007, 28:11-15.
45. Bakhshaee M., et al. Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study. Eur. Arch. Otorhinolaryngol. 2008, 265:525-530.
46. Bauer C.A., Brozoski T.J. Gabapentin. Prog. Brain Res. 2007, 166:287-301.
47. Simpson J.J., et al. The assessment of lamotrigine, an antiepileptic drug, in the treatment of tinnitus. Am. J. Otol. 1999, 20:627-631.
48. Guitton M.J., et al. New pharmacological strategies to restore hearing and treat tinnitus. Acta Otolaryngol. 2004, 124:411-415.
49. Azevedo A.A., Figueiredo R.R. Treatment of tinnitus with acamprosate. Prog. Brain Res. 2007, 166:273-277.
50. Denk D.M., et al. Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol. 1997, 117:825-830.
51. Domeisen H., et al. Caroverine in tinnitus treatment. Acta Otolaryngol. 1998, 118:606-608.
52. Figueiredo R.R., et al. Tinnitus treatment with memantine. Otolaryngol. Head Neck Surg. 2008, 138:492-496.
53. Akkuzu B., et al. Efficacy of misoprostol in the treatment of tinnitus in patients with diabetes and/or hypertension. Auris Nasus Larynx 2004, 31:226-232.
54. Yilmaz I., et al. Misoprostol in the treatment of tinnitus: a double-blind study. Otolaryngol. Head Neck Surg. 2004, 130:604-610.
55. Olzowy B., et al. Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial. Otol. Neurotol. 2007, 28:455-458.
56. Davies E., et al. The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus. Br. J. Audiol. 1994, 28:125-129.
57. Risey J.A., et al. Furosemide distinguishes central and peripheral tinnitus. Int. Tinnitus J. 1995, 1:99-103.
58. Hester T.O., et al. Cyclandelate in the management of tinnitus: a randomized, placebo-controlled study. Otolaryngol. Head Neck Surg. 1998, 118:329-332.
59. Lopez-Gonzalez M.A., et al. Sulpiride plus hydroxyzine decrease tinnitus perception. Auris Nasus Larynx 2007, 34:23-27.
60. Mazurek B., et al. Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study. J. Negat. Results Biomed. 2009, 8:3.
61. Rosenberg S.I., et al. Effect of melatonin on tinnitus. Laryngoscope 1998, 108:305-310.
62. Tyler R., et al. Identifying tinnitus subgroups with cluster analysis. Am. J. Audiol. 2008, 17:S176-S184.
63. Bauer C.A. Animal models of tinnitus. Otolaryngol. Clin. North Am. 2003, 36:267-285.
64. Turner J.G. Behavioral measures of tinnitus in laboratory animals. Prog. Brain Res. 2007, 166:147-156.
65. De Ridder D., et al. Amygdalohippocampal involvement in tinnitus and auditory memory. Acta Otolaryngol. Suppl. 2006, 556:50-53.
66. Hurko O., Ryan J.L. Translational research in central nervous system drug discovery. NeuroRx 2005, 2:671-682.
67. Enna S.J., Williams M. Challenges in the search for drugs to treat central nervous system disorders. J. Pharmacol. Exp. Ther. 2009, 329:404-411.
68. Langguth B., et al. Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative Meeting, Regensburg, July 2006. Prog. Brain Res. 2007, 166:525-536.
69. Kil J., et al. Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase. Hear. Res. 2007, 226:44-51.